TNFSF10 and Hepatic fibrosis: When administered to an N-nitrosodimethylamine-induced hepatic fibrosis SD rat model, HA-TRAIL showed a significantly higher delivery and a prolonged residency in the liver, compared to the unmodified TRAIL (>4 days) after single i.v. administration [166].